CF patients present increased levels of nuclear factor kB (NFκB) with chronic inflammation (Bodas, 2010), and also aberrant trafficking and degradation of Toll-like receptor 4 (TLR4), thereby enhancing inflammatory response (Bruscia et al., 2011). This evidence concerns the gene TLR4 and cystic fibrosis.